Previous Close | 9.04 |
Open | 12.00 |
Bid | 8.30 |
Ask | 9.60 |
Strike | 210.00 |
Expire Date | 2024-05-17 |
Day's Range | 10.30 - 12.00 |
Contract Range | N/A |
Volume | |
Open Interest | 1.92k |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.